658 Identification of a novel mutation in wilson disease patients from upper-austria: A genetic and clinical study

2006 ◽  
Vol 44 ◽  
pp. S243
Author(s):  
H. Hofer ◽  
C. Willheim-Polli ◽  
E. Hackl ◽  
P. Knoflach ◽  
C. Gabriel ◽  
...  
2008 ◽  
Vol 46 (06) ◽  
Author(s):  
H Hofer ◽  
C Willheim-Polli ◽  
F Hackl ◽  
P Knoflach ◽  
C Gabriel ◽  
...  

Author(s):  
Harald Hofer ◽  
Claudia Willheim-Polli ◽  
Peter Knoflach ◽  
Christian Gabriel ◽  
Wolfgang Vogel ◽  
...  

2012 ◽  
Vol 57 (9) ◽  
pp. 564-567 ◽  
Author(s):  
Harald Hofer ◽  
Claudia Willheim-Polli ◽  
Peter Knoflach ◽  
Christian Gabriel ◽  
Wolfgang Vogel ◽  
...  

Medicina ◽  
2021 ◽  
Vol 57 (2) ◽  
pp. 123
Author(s):  
Cigdem Yuce Kahraman ◽  
Ali Islek ◽  
Abdulgani Tatar ◽  
Özlem Özdemir ◽  
Adil Mardinglu ◽  
...  

Wilson disease (WD) (OMIM# 277900) is an autosomal recessive inherited disorder characterized by excess copper (Cu) storage in different human tissues, such as the brain, liver, and the corneas of the eyes. It is a rare disorder that occurs in approximately 1 in 30,000 individuals. The clinical presentations of WD are highly varied, primarily consisting of hepatic and neurological conditions. WD is caused by homozygous or compound heterozygous mutations in the ATP7B gene. The diagnosis of the disease is complicated because of its heterogeneous phenotypes. The molecular genetic analysis encourages early diagnosis, treatment, and the opportunity to screen individuals at risk in the family. In this paper, we reported a case with a novel, hotspot-located mutation in WD. We have suggested that this mutation in the ATP7B gene might contribute to liver findings, progressing to liver failure with a loss of function effect. Besides this, if patients have liver symptoms in childhood and/or are children of consanguineous parents, WD should be considered during the evaluation of the patients.


Hepatology ◽  
2000 ◽  
Vol 32 (6) ◽  
pp. 1329-1336 ◽  
Author(s):  
Luis García-Villarreal ◽  
Susan Daniels ◽  
Sarah H. Shaw ◽  
David Cotton ◽  
Margaret Galvin ◽  
...  

2001 ◽  
Vol 161 (2) ◽  
pp. 124-126 ◽  
Author(s):  
Kazuhiro Ohya ◽  
Wataru Abo ◽  
Hisamitsu Tamaki ◽  
Chieko Sugawara ◽  
Tetsuya Endo ◽  
...  

2012 ◽  
Vol 313 (1-2) ◽  
pp. 129-131 ◽  
Author(s):  
Jun-Young Lee ◽  
Young-Hyun Kim ◽  
Tae-Woo Kim ◽  
Sun-Young Oh ◽  
Dal-Sik Kim ◽  
...  

2006 ◽  
Vol 52 (3) ◽  
pp. 517-520 ◽  
Author(s):  
Ching-Wan Lam ◽  
Chloe M Mak

Abstract Background: We investigated the mechanisms leading to allele dropout—the nonamplification of 1 of the alleles—in PCR-based diagnosis of Wilson disease (WD). Methods: We extracted genomic DNA from blood samples from 6 WD patients (P1–P6) with allele dropouts detected in a previous study of WD in a Hong Kong Chinese population. We amplified the ATP7B gene by PCR and performed direct DNA sequencing of all exons of the ATP7B gene. To support the proposed mechanism of allele dropout, we used proofreading DNA polymerase, primer design avoiding single-nucleotide polymorphism sites, and duplex PCR. Results: Patients P1–P4 were all apparently homozygous for a known disease-causing mutation, c.2975C>T (p.P992L) in exon 13. Patient P5 was apparently homozygous for a novel mutation, c.2524G>A, and patient P6 was apparently homozygous for another known mutation, c.522_523insA (p.K175K-fs). In all cases, we determined that the patients were actually heterozygous for these mutations. Conclusion: Our results confirm that allele dropout is the mechanism causing apparent homozygosity of heterozygous mutations in these WD patients.


2000 ◽  
Vol 45 (5) ◽  
pp. 275-279 ◽  
Author(s):  
C.-C. Lee ◽  
J.-Y. Wu ◽  
F.-J. Tsai ◽  
H. Kodama ◽  
T. Abe ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document